The Akt–GSK-3 signaling cascade in the actions of dopamine

The rat nervous system

Paxinos, G. (1985) · Cited by 3,715

Dopamine receptors: from structure to function

MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633

A molecular mechanism for the effect of lithium on development.

Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,301

Transduction of Receptor Signals by ß-Arrestins

Lefkowitz, R. J., & Shenoy, S. K. (2005) · Science · doi:10.1126/science.1109237 · Cited by 1,727

GSK3 takes centre stage more than 20 years after its discovery

FRAME, S., & COHEN, P. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590001 · Cited by 1,433

Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation

Hoeflich, K. P., Luo, J., Rubie, E. A., Tsao, M.-S., Jin, O., & Woodgett, J. R. (2000) · Nature · doi:10.1038/35017574 · Cited by 1,393

β-Arrestin: a Protein that Regulates β-adrenergic Receptor Function

Lohse, M. J., Benovic, J. L., Codina, J., Caron, M. G., & Lefkowitz, R. J. (1990) · Science · doi:10.1126/science.2163110 · Cited by 1,220

Robustness of cellular functions

Stelling, J., Sauer, U., Szallasi, Z., Doyle, F. J., & Doyle, J. (2004) · Cell · doi:10.1016/j.cell.2004.09.008 · Cited by 1,049

An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior

Beaulieu, J.-M., Sotnikova, T. D., Marion, S., Lefkowitz, R. J., Gainetdinov, R. R., & Caron, M. G. (2005) · Cell · doi:10.1016/j.cell.2005.05.012 · Cited by 980

Role of β-Arrestin in Mediating Agonist-Promoted G Protein-Coupled Receptor Internalization

Ferguson, S. S. G., Downey, W. E., Colapietro, A.-M., Barak, L. S., Ménard, L., & Caron, M. G. (1996) · Science · doi:10.1126/science.271.5247.363 · Cited by 972

Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia

Emamian, E. S., Hall, D., Birnbaum, M. J., Karayiorgou, M., & Gogos, J. A. (2004) · Nature Genetics · doi:10.1038/ng1296 · Cited by 913

Basal ganglia

Alexander, G. E. (1998) · Cited by 890

The Neurobiology of Slow Synaptic Transmission

Greengard, P. (2001) · Science · doi:10.1126/science.294.5544.1024 · Cited by 867

DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS

Gainetdinov, R. R., Premont, R. T., Bohn, L. M., Lefkowitz, R. J., & Caron, M. G. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144206 · Cited by 860

Activation and targeting of extracellular signal-regulated kinases by β-arrestin scaffolds

Luttrell, L. M., Roudabush, F. L., Choy, E. W., Miller, W. E., Field, M. E., Pierce, K. L., & Lefkowitz, R. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041604898 · Cited by 831

Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade

Beaulieu, J.-M., Sotnikova, T. D., Yao, W.-D., Kockeritz, L., Woodgett, J. R., Gainetdinov, R. R., & Caron, M. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307921101 · Cited by 793

β-Arrestin-dependent, G Protein-independent ERK1/2 Activation by the β2 Adrenergic Receptor

Shenoy, S. K., Drake, M. T., Nelson, C. D., Houtz, D. A., Xiao, K., Madabushi, S., Reiter, E., Premont, R. T., Lichtarge, O., & Lefkowitz, R. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m506576200 · Cited by 759

Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum

Valjent, E., Pascoli, V., Svenningsson, P., Paul, S., Enslen, H., Corvol, J.-C., Stipanovich, A., Caboche, J., Lombroso, P. J., Nairn, A. C., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408305102 · Cited by 614

PKB/AKT: functional insights from genetic models

Scheid, M. P., & Woodgett, J. R. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096067 · Cited by 609

Involvement of the Extracellular Signal-Regulated Kinase Cascade for Cocaine-Rewarding Properties

Valjent, E., Corvol, J.-C., Pagès, C., Besson, M.-J., Maldonado, R., & Caboche, J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08701.2000 · Cited by 549

Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons

Chalecka-Franaszek, E., & Chuang, D.-M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8745 · Cited by 542

Molecular Targets of Lithium Action

Phiel, C. J., & Klein, P. S. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.789 · Cited by 515

Differential Kinetic and Spatial Patterns of β-Arrestin and G Protein-mediated ERK Activation by the Angiotensin II Receptor

Ahn, S., Shenoy, S. K., Wei, H., & Lefkowitz, R. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405878200 · Cited by 508

Inhibitory Phosphorylation of Glycogen Synthase Kinase-3 (GSK-3) in Response to Lithium

Zhang, F., Phiel, C. J., Spece, L., Gurvich, N., & Klein, P. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212635200 · Cited by 435

Regulation of Akt and glycogen synthase kinase-3β phosphorylation by sodium valproate and lithium

De Sarno, P., Li, X., & Jope, R. S. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00215-0 · Cited by 434

Glycogen Synthase Kinase-3β Haploinsufficiency Mimics the Behavioral and Molecular Effects of Lithium

O'Brien, W. T., Harper, A. D., Jové, F., Woodgett, J. R., Maretto, S., Piccolo, S., & Klein, P. S. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4753-03.2004 · Cited by 415

Multifaceted roles of β-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling

SHENOY, S. K., & LEFKOWITZ, R. J. (2003) · Biochemical Journal · doi:10.1042/bj20031076 · Cited by 405

Molecular Neurobiology of Drug Addiction

Chao, J., & Nestler, E. J. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.103730 · Cited by 346

Transgenic Mice Overexpressing Glycogen Synthase Kinase 3β: A Putative Model of Hyperactivity and Mania

Prickaerts, J., Moechars, D., Cryns, K., Lenaerts, I., van Craenendonck, H., Goris, I., Daneels, G., Bouwknecht, J. A., & Steckler, T. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5216-05.2006 · Cited by 341

Essential role of β-adrenergic receptor kinase 1 in cardiac development and function

Jaber, M., Koch, W. J., Rockman, H., Smith, B., Bond, R. A., Sulik, K. K., Ross, J., Lefkowitz, R. J., Caron, M. G., & Giros, B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.12974 · Cited by 341

Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia

Kapur, S., & Remington, G. (2001) · Annual Review of Medicine · doi:10.1146/annurev.med.52.1.503 · Cited by 324

A Nuclear Function of β-Arrestin1 in GPCR Signaling: Regulation of Histone Acetylation and Gene Transcription

Kang, J., Shi, Y., Xiang, B., Qu, B., Su, W., Zhu, M., Zhang, M., Bao, G., Wang, F., Zhang, X., et al. (2005) · Cell · doi:10.1016/j.cell.2005.09.011 · Cited by 318

AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test

Gould, T. D., Einat, H., Bhat, R., & Manji, H. K. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004535 · Cited by 314

Diverse Psychotomimetics Act Through a Common Signaling Pathway

Svenningsson, P., Tzavara, E. T., Carruthers, R., Rachleff, I., Wattler, S., Nehls, M., McKinzie, D. L., Fienberg, A. A., Nomikos, G. G., & Greengard, P. (2003) · Science · doi:10.1126/science.1089681 · Cited by 314

In Vivo Regulation of Glycogen Synthase Kinase-3β (GSK3β) by Serotonergic Activity in Mouse Brain

Li, X., Zhu, W., Roh, M.-S., Friedman, A. B., Rosborough, K., & Jope, R. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300439 · Cited by 300

Regulation of Akt Signaling by D2and D3Dopamine Receptors In Vivo

Beaulieu, J.-M., Tirotta, E., Sotnikova, T. D., Masri, B., Salahpour, A., Gainetdinov, R. R., Borrelli, E., & Caron, M. G. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5074-06.2007 · Cited by 269

A crucial role for GRK2 in regulation of endothelial cell nitric oxide synthase function in portal hypertension

Liu, S., Premont, R. T., Kontos, C. D., Zhu, S., & Rockey, D. C. (2005) · Nature Medicine · doi:10.1038/nm1289 · Cited by 251

Dopaminergic Supersensitivity in G Protein-Coupled Receptor Kinase 6-Deficient Mice

Gainetdinov, R. R., Bohn, L. M., Sotnikova, T. D., Cyr, M., Laakso, A., Macrae, A. D., Torres, G. E., Kim, K.-M., Lefkowitz, R. J., Caron, M. G., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00192-2 · Cited by 230

A Paradigm Shift in Brain Research

Carlsson, A. (2001) · Science · doi:10.1126/science.1066969 · Cited by 221

Cloning, expression, and chromosomal localization of beta-adrenergic receptor kinase 2. A new member of the receptor kinase family

Benovic, J. L., Onorato, J. J., Arriza, J. L., Stone, W. C., Lohse, M., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., Caron, M. G., & Lefkowitz, R. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98568-6 · Cited by 211

Enhanced Rewarding Properties of Morphine, but not Cocaine, in βarrestin-2 Knock-Out Mice

Bohn, L. M., Gainetdinov, R. R., Sotnikova, T. D., Medvedev, I. O., Lefkowitz, R. J., Dykstra, L. A., & Caron, M. G. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-32-10265.2003 · Cited by 210

Alteration in Kinase Activity But Not in Protein Levels of Protein Kinase B and Glycogen Synthase Kinase-3β in Ventral Prefrontal Cortex of Depressed Suicide Victims

Karege, F., Perroud, N., Burkhardt, S., Schwald, M., Ballmann, E., La Harpe, R., & Malafosse, A. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.04.036 · Cited by 208

Association of the D2 Dopamine Receptor Third Cytoplasmic Loop with Spinophilin, a Protein Phosphatase-1-interacting Protein

Smith, F. D., Oxford, G. S., & Milgram, S. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19894 · Cited by 201

The G-protein-coupled receptor kinases beta ARK1 and beta ARK2 are widely distributed at synapses in rat brain

Arriza, J., Dawson, T., Simerly, R., Martin, L., Caron, M., Snyder, S., & Lefkowitz, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-10-04045.1992 · Cited by 195

Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics

Li, X., Rosborough, K. M., Friedman, A. B., Zhu, W., & Roth, K. A. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706006547 · Cited by 191

Muscarinic Supersensitivity and Impaired Receptor Desensitization in G Protein–Coupled Receptor Kinase 5–Deficient Mice

Gainetdinov, R. R., Bohn, L. M., Walker, J. K. L., Laporte, S. A., Macrae, A. D., Caron, M. G., Lefkowitz, R. J., & Premont, R. T. (1999) · Neuron · doi:10.1016/s0896-6273(00)81048-x · Cited by 191

Antipsychotics alter the protein expression levels of β-catenin and GSK-3 in the rat medial prefrontal cortex and striatum

Alimohamad, H., Rajakumar, N., Seah, Y.-H., & Rushlow, W. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.036 · Cited by 187

Role of the ERK pathway in psychostimulant-induced locomotor sensitization

Valjent, E., Corvol, J.-C., Trzaskos, J. M., Girault, J.-A., & Hervé, D. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-20 · Cited by 175

G Protein-coupled Receptor Kinase 3 (GRK3) Gene Disruption Leads to Loss of Odorant Receptor Desensitization

Peppel, K., Boekhoff, I., McDonald, P., Breer, H., Caron, M. G., & Lefkowitz, R. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25425 · Cited by 165

Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction

Zhao, Z., Ksiȩżak-Reding, H., Riggio, S., Haroutunian, V. H., & Pasinetti, G. M. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.02.009 · Cited by 160

Further Evidence for Association of Variants in the AKT1 Gene with Schizophrenia in a Sample of European Sib-Pair Families

Schwab, S. G., Hoefgen, B., Hanses, C., Hassenbach, M. B., Albus, M., Lerer, B., Trixler, M., Maier, W., & Wildenauer, D. B. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.005 · Cited by 156

β-Arrestin/AP-2 Interaction in G Protein-coupled Receptor Internalization

Laporte, S. A., Miller, W. E., Kim, K.-M., & Caron, M. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108490200 · Cited by 153

Spinophilin Blocks Arrestin Actions in Vitro and in Vivo at G Protein-Coupled Receptors

Wang, Q., Zhao, J., Brady, A. E., et al. (2004) · Science · doi:10.1126/science.1098274 · Cited by 151

Association of AKT1 with schizophrenia confirmed in a Japanese population

Ikeda, M., Iwata, N., Suzuki, T., Kitajima, T., Yamanouchi, Y., Kinoshita, Y., Inada, T., & Ozaki, N. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.023 · Cited by 150

Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning

Lai, W., Xu, B., Westphal, K. G. C., Paterlini, M., Olivier, B., Pavlidis, P., Karayiorgou, M., & Gogos, J. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604994103 · Cited by 149

Dopamine-Independent Locomotor Actions of Amphetamines in a Novel Acute Mouse Model of Parkinson Disease

Sotnikova, T. D., Beaulieu, J., Barak, L. S., Wetsel, W. C., Caron, M. G., & Gainetdinov, R. R. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030271 · Cited by 141

Exercise activates the phosphatidylinositol 3-kinase pathway

Chen, M. J., & Russo‐Neustadt, A. A. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.12.001 · Cited by 136

Monoamine transporter pharmacology and mutant mice

Gainetdinov, R. R., Sotnikova, T. D., & Caron, M. G. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02044-8 · Cited by 129

The effects of clozapine on the GSK‐3‐mediated signaling pathway

Kang, U. G., Seo, M. S., Roh, M., Kim, Y., Yoon, S. C., & Kim, Y. S. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00082-1 · Cited by 118

Paradoxical Striatal Cellular Signaling Responses to Psychostimulants in Hyperactive Mice

Beaulieu, J., Sotnikova, T. D., Gainetdinov, R. R., & Caron, M. G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606062200 · Cited by 117

Association of AKT1 haplotype with the risk of schizophrenia in Iranian population

Bajestan, S. N., Sabouri, A. H., Nakamura, M., Takashima, H., Keikhaee, M. R., Behdani, F., Bordbar, M. R. F., Sargolzaee, M. R., Bajestan, M. N., Sabouri, Z., et al. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30291 · Cited by 83

Not only lithium: regulation of glycogen synthase kinase-3 by antipsychotics and serotonergic drugs

Beaulieu, J. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706006857 · Cited by 73

β-Arrestin Goes Nuclear

Beaulieu, J., & Caron, M. G. (2005) · Cell · doi:10.1016/j.cell.2005.11.010 · Cited by 44

The physiology, signaling, and pharmacology of dopamine receptors

Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763

PI3K/Akt: getting it right matters

Franke, T. F. (2008) · Oncogene · doi:10.1038/onc.2008.313 · Cited by 695

Akt/GSK3 Signaling in the Action of Psychotropic Drugs

Beaulieu, J.-M., Gainetdinov, R. R., & Caron, M. G. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145634 · Cited by 522

Dopamine receptors –IUPHAR R eview 13

Beaulieu, J., Espinoza, S., & Gainetdinov, R. R. (2015) · British Journal of Pharmacology · doi:10.1111/bph.12906 · Cited by 521

GSK-3 is a master regulator of neural progenitor homeostasis

Kim, W.-Y., Wang, X., Wu, Y., Doble, B. W., Patel, S., Woodgett, J. R., & Snider, W. D. (2009) · Nature Neuroscience · doi:10.1038/nn.2408 · Cited by 399